HIV prevention drug hailed as a 'breakthrough' gets FDA approval

A pharmacist holds a vial of lenacapavir, the injectable drug that prevents HIV infection. On June 18, the FDA approved the drug for use in the U.S.

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One looming question: Will it be affordable for lower resource countries?

(Image credit: Nardus Engelbrecht)